Aeterna Zentaris (AEZS) News Today → The Best AI Stock to Own in the World Today is Trading for Just $25 (From Banyan Hill Publishing) (Ad) Free AEZS Stock Alerts $1.96 0.00 (-0.19%) (As of 04/26/2024 08:52 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineAeterna Zentaris Inc. (NASDAQ:AEZS) Short Interest Down 22.1% in Aprilamericanbankingnews.com - April 29 at 4:16 AM12 ChatGPT Penny Stock Picks Right Nowfinance.yahoo.com - April 28 at 12:19 PMContrasting BioMarin Pharmaceutical (NASDAQ:BMRN) and Aeterna Zentaris (NASDAQ:AEZS)americanbankingnews.com - April 28 at 1:44 AMAeterna Zentaris (NASDAQ:AEZS) Now Covered by StockNews.comamericanbankingnews.com - April 22 at 2:18 AMAuxly Cannabis Group: Top 10 Undervalued Healthcare Sector Stocks on TSX (XLY)theglobeandmail.com - April 2 at 10:59 AMCeapro Receives Final Court Approval for Merger with Aeterna Zentarisglobenewswire.com - March 28 at 7:55 AMAEterna Zentaris: Q4 Earnings Insightsbenzinga.com - March 27 at 10:45 AMAeterna Zentaris Reports Fourth Quarter and Full Year 2023 Financial Results and Announces Completion of Enrollment in Ongoing Pivotal DETECT-Trial for the Diagnosis of Childhood-Onset Growth Hormone Deficiencyglobenewswire.com - March 27 at 8:05 AMAeterna Zentaris Inc: Aeterna Zentaris and Ceapro Merger Approved by Securityholders at Special Meetingsfinanznachrichten.de - March 13 at 7:32 AMAeterna Zentaris and Ceapro Merger Approved by Securityholders at Special Meetingsglobenewswire.com - March 12 at 2:10 PMAeterna Zentaris Inc.thestreet.com - February 28 at 8:06 AMLeading Independent Proxy Advisory Firm ISS Recommends Aeterna Zentaris and Ceapro Securityholders Vote FOR the Arrangement Agreement to Approve the Merger of Equals to Create a Diversified Biopharmaceutical Companyglobenewswire.com - February 26 at 7:30 AMAeterna Zentaris Issues Letter to Shareholders and Management Proxy Circular Ahead of Special Meeting of Shareholders to Approve Merger of Equals with Ceaproglobenewswire.com - February 15 at 5:50 PMmarketbeat.com - December 14 at 7:47 AMAEterna Zentaris Inc AEZSmorningstar.com - November 14 at 9:06 PMAeterna Zentaris GAAP EPS of -$0.85msn.com - November 9 at 9:05 AMAeterna Zentaris Reports Third Quarter 2023 Financial Resultsfinance.yahoo.com - November 9 at 9:05 AMAEterna Zentaris: Stocks trading at Less Than Cash Value on TSX (AEZS)theglobeandmail.com - November 6 at 5:42 PMAEterna Zentaris: Top 10 Undervalued Biotechnology Industry Stocks (AEZS)theglobeandmail.com - October 30 at 7:52 PMAeterna Zentaris to Participate at the Virtual Investor Ask the CEO Conferencefinance.yahoo.com - October 11 at 8:25 AMClosing Bell: Aeterna Zentaris Inc down on Monday (AEZS)theglobeandmail.com - September 12 at 7:32 PMAeterna Zentaris to Present at the H.C. Wainwright 25th Annual Global Investment Conferencefinance.yahoo.com - September 5 at 8:49 AMClosing Bell: Aeterna Zentaris Inc flat on Tuesday (AEZS)theglobeandmail.com - August 15 at 11:04 PMH.C. Wainwright Keeps Their Buy Rating on Aeterna Zentaris (AEZS)markets.businessinsider.com - August 10 at 4:43 PMAeterna Zentaris (AEZS) Reports Q2 Loss, Tops Revenue Estimatesfinance.yahoo.com - August 9 at 12:29 PMAeterna Zentaris Outlines Progress on Development Pipeline Programs and Provides Corporate Updatefinance.yahoo.com - July 13 at 9:18 AMAeterna Zentaris Inc: Aeterna Zentaris Announces Results of Virtual 2023 Meeting of Shareholdersfinanznachrichten.de - June 15 at 8:33 AMClosing Bell: Aeterna Zentaris Inc down on Friday (AEZS)theglobeandmail.com - May 26 at 7:15 PMClosing Bell: Aeterna Zentaris Inc down on Tuesday (AEZS)theglobeandmail.com - May 17 at 2:55 PMAeterna Zentaris Announces Virtual 2023 Meeting of Shareholdersfinance.yahoo.com - May 15 at 5:50 PMH.C. Wainwright Reaffirms Their Buy Rating on Aeterna Zentaris (AEZS)markets.businessinsider.com - May 12 at 8:40 AMAeterna Zentaris Inc: Aeterna Zentaris Reports First Quarter 2023 Financial Resultsfinanznachrichten.de - May 10 at 4:21 AMAeterna Zentaris Reports First Quarter 2023 Financial Resultsfinance.yahoo.com - May 9 at 6:19 PMClosing Bell: Aeterna Zentaris Inc down on Wednesday (AEZS)theglobeandmail.com - April 27 at 9:20 AMClosing Bell: Aeterna Zentaris Inc up on Thursday (AEZS)theglobeandmail.com - April 6 at 5:44 PMClosing Bell: Aeterna Zentaris Inc up on Wednesday (AEZS)theglobeandmail.com - April 6 at 12:44 PMAeterna (AEZS) Falls 5% on US Sales Halt of Growth Hormone Drugfinance.yahoo.com - April 6 at 12:44 PMAeterna Zentaris Inc: Aeterna Zentaris Provides Update on Macrilen (Macimorelin), Reiterates Advancement of Pediatric DETECT Trialfinanznachrichten.de - April 5 at 4:34 PMAeterna Zentaris Provides Update on Macrilen® (Macimorelin), Reiterates Advancement of Pediatric DETECT Trialfinance.yahoo.com - April 5 at 8:36 AMAeterna Zentaris (AEZS) Reports Q4 Loss, Tops Revenue Estimatesfinance.yahoo.com - March 23 at 12:36 PMAeterna Zentaris Reports Fourth Quarter and Full Year 2022 Financial Resultsfinancialpost.com - March 23 at 8:22 AMPharmanovia to Market GHRYVELIN™ (Macimorelin) in the European Economic Area (EEA) and UK as Diagnostic Test for Growth Hormone Deficiency (GHD)finance.yahoo.com - March 16 at 9:25 AMAeterna Zentaris Inc: Aeterna Zentaris Provides Business Update and Outlines Key Upcoming Milestonesfinanznachrichten.de - January 17 at 1:29 PMAeterna Zentaris Shelves Early-Stage Vaccine Programs, Including COVID-19benzinga.com - January 17 at 1:13 PMAeterna Zentaris Provides Business Update and Outlines Key Upcoming Milestonesfinance.yahoo.com - January 17 at 8:28 AMAeterna Zentaris to Present at the Virtual Investor 2023 Companies to Watch Eventfinance.yahoo.com - January 10 at 9:39 AMAeterna Zentaris (AEZS) Reports Q3 Loss, Tops Revenue Estimatesfinance.yahoo.com - November 3 at 2:54 PMAeterna Zentaris Reports Third Quarter 2022 Financial Resultsfinance.yahoo.com - November 3 at 9:53 AMAEZS Aeterna Zentaris Inc.seekingalpha.com - October 14 at 8:54 AMAeterna Zentaris Set to Regain Full Rights to Macrilen™ (Macimorelin) in U.S. and Canada from Novo Nordiskfinance.yahoo.com - August 29 at 9:27 AM Get Aeterna Zentaris News Delivered to You Automatically Sign up to receive the latest news and ratings for AEZS and its competitors with MarketBeat's FREE daily newsletter. Email Address These AI trades triggered this morning (545% return) (Ad)If you think a market crash is possible in 2024, I don't know why you're not using this yet. Click Here To Get Your Free Copy AEZS Media Mentions By Week AEZS Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AEZS News Sentiment▼0.360.34▲Average Medical News Sentiment AEZS News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AEZS Articles This Week▼40▲AEZS Articles Average Week Get Aeterna Zentaris News Delivered to You Automatically Sign up to receive the latest news and ratings for AEZS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: AKTX News ATHE News ELAB News MBRX News GHSI News GRTX News ERNA News NCNA News MTEM News VIRI News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AEZS) was last updated on 4/29/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldAI finds its first serious applicationWall Street StarHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingRich Dad Poor Dad Author Shocks Millions With 2024 Crash WarningAmerican Hartford Gold GroupHis win rate puts Warren Buffett to shame… Investing DailyTrump is sounding the alarmPreserve Gold Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aeterna Zentaris Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
